Moumita Bose

Moumita Bose

Auto-generated profile, based on publicly available information

Moumita Bose

Kao Autoimmunity Institute and Division of Rheumatology Cedars‐Sinai Medical Center Los Angeles CA USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in Arthritis & Rheumatology
Verified
Journal Article
Open access
EMErica N. Montano
Erica N. Montano
MBMoumita Bose
Moumita Bose
LHLihong Huo
Lihong Huo
GTGantsetseg Tumurkhuu
Gantsetseg Tumurkhuu
GSGabriela De Los Santos
Gabriela De Los Santos
CJCaroline A. Jefferies
Caroline A. Jefferies
Objective: We aimed to investigate the hypothesis that interferon (IFN)–stimulated gene (ISG) expression in systemic lupus erythematosus (SLE) monocytes is linked to changes in metabolic reprogramming and epigenetic regulation of ISG expression.Methods: Monocytes from healthy volunteers and patients with SLE at baseline or following IFNα treatment were analyzed by extracellular flux analysis, proteomics, metabolomics, chromatin immunoprecipitation, and gene expression. The histone demethylases KDM6A/B were inhibited using glycogen synthase kinase J4 (GSK‐J4). GSK‐J4 was tested in pristane and resiquimod (R848) models of IFN‐driven SLE.Results: SLE monocytes had enhanced rates of glycolysis and oxidative phosphorylation compared to healthy control monocytes, as well as increased levels of isocitrate dehydrogenase and its product, α‐ketoglutarate (α‐KG). Because α‐KG is a required cofactor for histone demethylases KDM6A and KDM6B, we hypothesized that IFNα may be driving “trained immune” responses through altering histone methylation. IFNα priming (day 1) resulted in a sustained increase in the expression of ISGs in primed cells (day 5) and enhanced expression on restimulation with IFNα. Importantly, decreased H3K27 trimethylation was observed at the promoters of ISGs following IFNα priming. Finally, GSK‐J4 (KDM6A/B inhibitor) resulted in decreased ISG expression in SLE patient monocytes, as well as reduced autoantibody production, ISG expression, and kidney pathology in R848‐treated BALB/c mice.Conclusion: Our study suggests long‐term IFNα exposure alters the epigenetic regulation of ISG expression in SLE monocytes via changes in immunometabolism, a mechanism reflecting trained immunity to type I IFN. Importantly, it opens the possibility that targeting histone‐modifying enzymes, such as KDM6A/B, may reduce IFN responses in SLE. image

31 March 2011 in Inorganic Chemistry
Verified
Journal Article
Closed access
MBMoumita Bose
Moumita Bose
GMGolam Moula
Golam Moula
ABAmeerunisha Begum
Ameerunisha Begum
Sabyasachi SarkarSabyasachi Sarkar
Sabyasachi Sarkar

29 April 2019 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
GMGolam Moula
Golam Moula
MBMoumita Bose
Moumita Bose
Sabyasachi SarkarSabyasachi Sarkar
Sabyasachi Sarkar
A new molybdenum complex, [Et4N]2[Mo(PPh3)(mnt)2–OMo(mnt)2]·CH2Cl2·½H2O (1, mnt = maleonitrile dithiolene = S2C2(CN)2), with unique structural features was synthesized, in which the fragment {Mo(PPh3)(mnt)2–} was attached to another important {–OMo(mnt)2} moiety. The structure of 1 was formed by the association of both the oxo and desoxo motifs of the dimethylsulfoxide reductase (DMSOR) class of enzymes. This dissymmetrical binuclear complex 1 is rare, and it utilized the basic inorganic aspects to accommodate both moieties; under basic conditions, it was converted to (Et4N)2[MoO(mnt)2] (2). Similarly, when treated with PhSH and PPh3, it was completely converted to [Et4N]2[Mo(PPh3)(mnt)2(SPh)] (3) (J. Am. Chem. Soc., 2006, 128, 4196–4197). The chemistry of 1 was analyzed with regard to its synthesis, reactivity, crystal structure, and spectroscopic and photophysical properties. In addition, the results were complemented with DFT calculations.